Gelsy Naranjo, General Practice Medicare: Not Enrolled in Medicare Practice Location: 660 Parrington Oval, Norman, OK 73019 Phone: 405-325-0311 |
Christopher Edge, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 500 E Robinson St, Suite 300, Norman, OK 73071 Phone: 405-360-1118 Fax: 405-360-7177 |
Vytautas Ringus, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 825 E Robinson St, Norman, OK 73071 Phone: 405-364-7900 Fax: 405-366-6214 |
Bruce Kevin Remy, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1828 Cedar Hill Rd, Norman, OK 73072 Phone: 405-360-4436 |
News Archive
The death rate among adults in South Africa increased significantly from 1997 through 2004, according to a government report released on Thursday by Statistics South Africa, the New York Times reports.
Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, today announced it has closed its previously announced public offering of 5,500,000 shares of its common stock at a price of $21.00 per share.
Harvest Technologies Corp. announced today that the company sponsored 48-patient IDE clinical trial conducted at seven sites in the U.S. and one site in India using the company's Bone Marrow Aspiration Concentrate (BMAC) System to treat patients with non-reconstructable Critical Limb Ischemia (CLI) has completed enrollment. Mark D. Iafrati, M.D. Chief of Vascular Surgery at Tufts Medical Center in Boston, directed the study.
A team of Harvard School of Public Health (HSPH) scientists report finding a molecular "switch" that can "turn off" some cellular processes that are protective against aging and metabolic diseases. While more research is needed, the findings may open doors for new drug treatments to halt or slow development of metabolic diseases like type 2 diabetes or heart disease. The research findings appear in the December 1, 2010 issue of Cell Metabolism.
› Verified 9 days ago